Pharmaceutical industry news

Deep Learning System Detects Lesions in Sacroiliac Joints

PTC Therapeutics at cantor healthcare conference: sephience drives growth By Investing.com

Can Vaginal Estrogen Cream Erase Signs of Aging on Your Face?

NHSR, Exempt, Expedited, or Full Board? A Plain-Language Guide to Potential Review Pathways

FDA Expands Hyrnuo Use in HER2-Mutated Lung Cancer

Université Paris Cité at EAIE 2026 in Glasgow

Why Pharma's Next AI Challenge Is Supervision, Not Adoption

US FDA extends review of Exelixis’ cancer drug

WATCH: Conversations on America's global biotech leadership

How the mosquito’s carbon dioxide sense gets an internal boost

Novartis drags peers down with triple asset stumble

FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer

The future of RAS inhibitors

How Pharmaceutical Logistics Comes Together

5 things to know in life sciences: Week of Sept. 7, 2026

FDA extends Exelixis' zanzalintinib review by three months, pushing decision to March 2027

USFDA Imposes Partial Clinical Hold on Biohaven's Epilepsy Drug Over Rodent Findings

Pneumococcal disease: cases caused by serotypes not covered by PCV13

Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Pre...

Pneumococcal disease: cases caused by serotypes covered by PCV13

Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevena...

Cancer drug shortages keep disrupting patient care

Eli Lilly completes acquisition of AtaiBeckley, initiates delisting from Nasdaq

Novo Holdings and leading international funds are investing nearly DKK 60m in a new Danish biotech company

Top Investor Urges Novartis for Stronger Acquisition Oversight After M&A and Trial Setbacks

Dr. J.P. McAleer – Lapiplasty®S4A

US FDA extends review of Exelixis' cancer drug

Beyond Simple Allometric Scaling: Why Time-Course Methods Win for First-in-Human Predictions

ERS 2026: BMI, type-2 inflammation, and asthma attack risk

New light-emitting nanoparticles can detect subtle chemical differences to enhance pharmaceutical manufacturing, pollution prevention and more

Lundbeck drug candidate granted another US FDA designation

AbbVie’s Atogepant delivers positive Phase 3 results in menstrual migraine

AstraZeneca’s Etcamah falls short of key Phase III endpoint in breast cancer trial

Ανάκληση του αριθμού παρτίδας 14 L156 D της βρεφικής τροφής με ονομασία πώλησης “Bio/Organic Apple-Peach-Mango, 6+ months” και εμπορική ονομασία “LUPILU”

India’s biotech growth needs more long-term capital, says expert

This Week in Science: Poop Concrete, Hot Ice, And More!

Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'

Frazier adds $1.1B+ to small and mid-sized biotech fund

Kenya's wealthy Merali family acquires stake in pharmaceutical glass plant

Eppendorf launches refrigerated Centrifuge 5811 R

Report an outbreak of acute respiratory infection in an adult social care setting

You can use this service to report an outbreak if you provide adult social care. This includes a car...

Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared.

The Download: biotech’s future and cheaper, cleaner steel

Sterlitech launches benchtop membrane filtration systems

FDA extends review of Exelixis drug application for metastatic colorectal cancer

The tadpoles that don't care about their siblings

Kyoto University signs agreement with Taiwan's Ministry of Education regarding the Taiwan Global Pathfinders Initiative

Profitable Biotech Incyte Forms Handle As Institutional Buyers Load Up On Stock

Transition of the Icelandic Medicines Agency’s Website in Full Swing

mRNA cancer vaccines’ biggest barriers to market

U.S. FDA extends review of Exelixis’ cancer drug

ANMAT evaluó y liberó más de 430 lotes de vacunas entre junio de 2025 y mayo de 2026

België moet nu investeren in digitale pathologie om morgen betere zorg te bieden

FDA Extends Review Timeline for Exelixis Cancer Drug

Frost & Sullivan presents the "GLOBAL GENE THERAPY CRDMO TECHNOLOGY INNOVATION LEADERSHIP AWARD" to PackGene Biotech Inc.

Moins de papier, plus de numérique : nous faisons évoluer nos pratiques !

‘It Restored My Hope’: How the Margaret Foti Scholarship Helped Tsedey Tsegaye Reclaim Her Future

Biohaven’s epilepsy drug hit with FDA clinical hold

How Investors May Respond To SELLAS Life Sciences Group (SLS) Phase 3 Trial Nears

The Early Scale: CPC Biotech and Multiply Labs smoothen cell therapy automation bottleneck

Shanghai Henlius Biotech Says NDA For 120 Mg Biosimilar Denosumab HLX14 Accepted By NMPA

MRKON Risks Explained: KEYTRUDA Dependence, Patent Expiry, Clinical Trials and Tokenized Stock Risk